Our Chief Scientist, Professor Mohammad Najlah was delighted to host Professor Weiguang Wang, from the University of Wolverhampton and Vinodh Kannappan, Chief Technology Officer at Disulfican Ltd, to his Anglia Ruskin University labs. During their visit, the group explored numerous opportunities to strengthen their long-term collaboration. Professor Najlah also toured the visitors round our state-of-the-art […]
GMPriority Pharma is thrilled to announce the successful scale-up of our pioneering liposomal dry powder technology, dry SAIFx®, following a highly productive two-year Research and Development Knowledge Transfer Partnership (KTP) with Anglia Ruskin University. This innovative advancement marks a significant milestone in liposomal encapsulation technology, showcasing our commitment to scientific excellence and quality. Revolutionising […]
We are proud to announce that GMPriority Pharma has achieved the prestigious Good Manufacturing Practice (GMP) status, certified by NQA. This significant milestone underscores our continued commitment to maintaining the highest standards of quality and safety in the research and manufacturing of innovative liposomal products. What is GMP and Why is it Important? Good Manufacturing […]
lipolife, a leading, innovative brand in liposomal health supplements, is proud to announce that it has been awarded an “Outstanding” grade by Innovate UK for its Knowledge Transfer Partnership (KTP) with Anglia Ruskin University. This prestigious recognition underscores our commitment to advancing scientific excellence and innovation in liposomal technology. Innovate UK, the UK’s innovation agency, […]
